R.S. Ipratrop 1.25: Levosalbutamol & Ipratropium Bromide Solution

May 31, 2024

R.S. IPRATROP 1.25

Levosalbutamol & Ipratropium Bromide Respiratory Solution

R.S. IPRATROP 1.25 combination of Levosalbutamol & Ipratropium Bromide Respiratory Solution is a combination medication widely used in the treatment of respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. This combination provides dual bronchodilatory effects, enhancing breathing and alleviating symptoms.

Uses :

Chronic Obstructive Pulmonary Disease (COPD): This solution is highly effective in managing COPD by improving airflow and reducing symptoms.
Asthma Management: It is also used to control and prevent asthma symptoms, ensuring better respiratory function and quality of life.

Dosage :

Standard Dosage: The typical dosage is one nebulizer treatment administered three to four times a day, as prescribed by a healthcare provider.
Adjustment: Dosage may be adjusted based on individual response and severity of the condition, under medical supervision.

Side Effects :

Common Side Effects:
- Dry mouth
- Cough
- Headache
Serious Side Effects:
- Increased heart rate
- High blood pressure
- Allergic reactions

Precautions :

Monitoring: Regular monitoring of lung function and cardiovascular health is recommended during treatment.
Caution: Use with caution in patients with heart conditions, hypertension, or severe allergies.

Mechanism of Action :

Levosalbutamol: Acts as a beta-agonist, relaxing bronchial smooth muscles and improving airflow.
Ipratropium Bromide: Functions as an anticholinergic, inhibiting bronchoconstriction and reducing mucus secretion.

Conclusion :

Levosalbutamol & Ipratropium Bromide Respiratory Solution is a highly effective treatment for COPD and asthma. By combining the benefits of a beta-agonist and an anticholinergic, it provides comprehensive relief from respiratory symptoms. Adhering to prescribed dosages and taking necessary precautions can help maximize benefits and minimize risks.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.